MedCity News January 29, 2019
Kevin Truong

The new funding, led by by existing investor Greenoaks Capital, is simply the latest in a number of monster investments in insuretech companies looking to broach Medicare Advantage

Investors are hungry to support startups looking to challenge incumbent health plans in the red-hot Medicare Advantage space

The latest example is San Francisco-based company Clover Health raising another $500 million led by existing investor Greenoaks Capital, even after a series of missteps a few years back that culminated in co-founder and former CTO Kris Gale stepping down from his role.

The new funding amount was initially reported by TechCrunch and independently verified by MedCity News.

As part of the financing, Clover Health CTO Andrew Toy has been promoted...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Insurance, Investments, Medicare Advantage, Trends
Medicare Advantage Enrollees Use Less Home Health Care In Their Final Days Than Traditional Medicare Patients
Medicare Advantage insurers ranked by prior authorization denial rates | 2023
Why Yale New Haven is having 'frank conversations' about MA
Medicare Advantage insurers made about 50 million prior authorization determinations in 2023
Cigna's Medicare Advantage sale on track to close in Q1

Share This Article